ArticleJournal of translational internal medicine2023

Efficacy and safety of QL0911 in adult patients with chronic primary immune thrombocytopenia: A multicenter, randomized, double-blind, placebo-controlled, phase III trial.

Hu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.